De novo branching cascades for structural and functional diversity in small molecules

Nature Communications

Volumn 6, Issue , 2015, Pages

  Garcia Castro, Miguel ^a   Kremer, Lea ^a,b   Reinkemeier, Christopher D ^a   Unkelbach, Christian ^b   Strohmann, Carsten ^b   Ziegler, Slava ^a   Ostermann, Claude ^a   Kumar, Kamal ^a,b  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLENEDICARBOXYLIC ACID DIMETHYL ESTER; ALLENE ESTER; CARBOXYLIC ACID; COLCHICINE; ESTER DERIVATIVE; HETEROCYCLIC COMPOUND; HYDROXYLAMINE; N PHENYLHYDROXYLAMINE; SONIC HEDGEHOG PROTEIN; TUBULIN MODULATOR; UNCLASSIFIED DRUG; VINCA ALKALOID;

BIOACTIVITY; BIOCHEMICAL COMPOSITION; INHIBITOR; MEDICINE; MOLECULAR ANALYSIS; SIGNALING;

3T3 CELL LINE; ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG POTENCY; DRUG SYNTHESIS; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; IC50; MICROTUBULE ASSEMBLY; MOLECULAR BIOLOGY; MOLECULAR LIBRARY; MOLECULAR MODEL; MOLECULE; NONHUMAN; SIGNAL TRANSDUCTION;

ERINACEIDAE;

EID: 84925061498     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7516     Document Type: Article

References (66)

1. Shelat, A. A. & Guy, R. K. Scaffold composition and biological relevance of screening libraries. Nat. Chem. Biol. 3, 442-446 (2007).
2. Dandapani, S. & Marcaurelle, L. A. Accessing new chemical space for 'undruggable' targets. Nat. Chem. Biol. 6, 861-863 (2010).
3. Ibbeson, B. M. et al. Diversity-oriented synthesis as a tool for identifying new modulators of mitosis. Nat. Commun. 5, 3155 (2014).
4. Villar, H. O. & Hansen, M. R. Design of chemical libraries for screening. Expert Opin. Drug Discov. 4, 1215-1220 (2009).
5. Burke, M. D., Berger, E. M. & Schreiber, S. L. Generating diverse skeletons of small molecules combinatorially. Science 302, 613-618 (2003).
6. Lee, M. L. & Schneider, G. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J. Comb. Chem. 3, 284-289 (2001).
7. Renner, S. et al. Bioactivity-guided mapping and navigation of chemical space. Nat. Chem. Biol. 5, 585-592 (2009).
8. Ertl, P., Jelfs, S., Muhlbacher, J., Schuffenhauer, A. & Selzer, P. Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds. J. Med. Chem. 49, 4568-4573 (2006).
9. Tan, D. S. Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat. Chem. Biol. 1, 74-84 (2005).
10. Kumar, K. & Waldmann, H. Synthesis of natural product inspired compound collections. Angew. Chem. Int. Ed. Engl. 48, 3224-3242 (2009).
11. Burke, M. D. & Schreiber, S. L. A planning strategy for diversity-oriented synthesis. Angew. Chem. Int. Ed. Engl. 43, 46-58 (2004).
12. Marcaurelle, L. A. et al. An aldol-based build/couple/pair strategy for the synthesis of medium- and large-sized rings: discovery of macrocyclic histone deacetylase inhibitors. J. Am. Chem. Soc. 132, 16962-16976 (2010).
13. Morton, D., Leach, S., Cordier, C., Warriner, S. & Nelson, A. Synthesis of natural-product-like molecules with over eighty distinct scaffolds. Angew. Chem. Int. Ed. Engl. 48, 104-109 (2009).
14. Oguri, H. & Schreiber, S. L. Skeletal diversity via a folding pathway: Synthesis of indole alkaloid-like skeletons. Org. Lett. 7, 47-50 (2005).
15. Kwon, O., Park, S. B. & Schreiber, S. L. Skeletal diversity via a branched pathway: Efficient synthesis of 29 400 discrete, polycyclic compounds and their arraying into stock solutions. J. Am. Chem. Soc. 124, 13402-13404 (2002).
16. Kumagai, N., Muncipinto, G. & Schreiber, S. L. Short synthesis of skeletally and stereochemically diverse small molecules by coupling Petasis condensation reactions to cyclization reactions. Angew. Chem. Int. Ed. Engl. 45, 3635-3638 (2006).
17. Robbins, D. et al. Synthesis of natural-product-like scaffolds in unprecedented efficiency via a 12-fold branching pathway. Chem. Sci. 2, 2232-2235 (2011).
18. Morrison, K. C. & Hergenrother, P. J. Natural products as starting points for the synthesis of complex and diverse compounds. Nat. Prod. Rep. 31, 6-14 (2014).
19. Huigens, R. W. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nat. Chem. 5, 195-202 (2013).
20. Beckmann, H. S. G. et al. A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling. Nat. Chem. 5, 861-867 (2013).
21. Cordier, C., Morton, D., Murrison, S., Nelson, A. & O'Leary-Steele, C. Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries. Nat. Prod. Rep. 25, 719-737 (2008).
22. Newman, D. J. & Cragg, G. M. Natural product scaffolds as leads to drugs. Future Med. Chem. 1, 1415-1427 (2009).
23. Firn, R. D. & Jones, C. G. Natural products - a simple model to explain chemical diversity. Nat. Prod. Rep. 20, 382-391 (2003).
24. Fischbach, M. A. & Clardy, J. One pathway, many products. Nat. Chem. Biol. 3, 353-355 (2007).
25. Maimone, T. J. & Baran, P. S. Modern synthetic efforts toward biologically active terpenes. Nat. Chem. Biol. 3, 396-407 (2007).
26. Razzak, M. & De Brabander, J. K. Lessons and revelations from biomimetic syntheses. Nat. Chem. Biol. 7, 865-875 (2011).
27. Tietze, L. F. Domino reactions in organic synthesis. Chem. Rev. 96, 115-136 (1996).
28. Nicolaou, K. C., David, J. E. & Paul, G. B. Cascade reactions in total synthesis. Angew. Chem. Int. Ed. Engl. 45, 7134-7186 (2006).
29. Liu, W., Khedkar, V., Baskar, B., Schurmann, M. & Kumar, K. Branching cascades: a concise synthetic strategy targeting diverse and complex molecular frameworks. Angew. Chem. Int. Ed. Engl. 50, 6900-6905 (2011).
30. Padwa, A., Kline, D. N. & Norman, B. H. Synthesis of the benzazepin-4-one ring-system via dipolar cyclo-addition of n-phenylnitrones with activated allenes. J. Org. Chem. 54, 810-817 (1989).
31. Padwa, A., Bullock, W. H., Kline, D. N. & Perumattam, J. Heterocyclic synthesis via the reaction of nitrones and hydroxylamines with substituted allenes. J. Org. Chem. 54, 2862-2869 (1989).
32. Wilkens, J., Kuhling, A. & Blechert, S. Hetero-cope rearrangements.6. short and stereoselective syntheses of 2-vinylindoles by a tandem-process. Tetrahedron 43, 3237-3246 (1987).
33. Mo, D. L., Wink, D. J. & Anderson, L. L. Solvent-controlled bifurcated cascade process for the selective preparation of dihydrocarbazoles or dihydropyridoindoles. Chemistry 20, 13217-13225 (2014).
34. Pecak, W. H., Son, J., Burnstine, A. J. & Anderson, L. L. Synthesis of 1,4-enamino ketones by [3,3]-rearrangements of dialkenylhydroxylamines. Org. Lett. 16, 3440-3443 (2014).
35. Wirth, T. & Blechert, S. Synthesis of 2,3-disubstituted indoles. Synlett 717-718 (1994).
36. Nguyen, T. B., Martel, A., Dhal, R. & Dujardin, G. N-benzyl aspartate nitrones: unprecedented single-step synthesis and [3 + 2] cycloaddition reactions with alkenes. Org. Lett. 10, 4493-4496 (2008).
37. Zhang, X. et al. Asymmetric synthesis of α,α-disubstituted amino acids by cycloaddition of (e)-ketonitrones with vinyl ethers. Org. Lett. 16, 1936-1939 (2014).
38. Devkota, K. P. et al. Compounds from Simarouba berteroana which inhibit proliferation of NF1-defective cancer cells. Phytochem. Lett. 7, 42-45 (2014).
39. Cebrian-Torrejon, G. et al. Alkaloids from Rutaceae: activities of canthin-6-one alkaloids and synthetic analogues on glioblastoma stems cells. Medchemcomm 3, 771-774 (2012).
40. Srihari, P., Yaragorla, S. R., Basu, D. & Chandrasekhar, S. Tris(pentafluorophenyl)borane-catalyzed synthesis of N-benzyl pyrrolidines. Synthesis 2646-2648 (2006).
41. Singh, A., Loomer, A. L. & Roth, G. P. Synthesis of oxindolyl pyrazolines and 3-amino oxindole building blocks via a nitrile imine [3 + 2] cycloaddition strategy. Org. Lett. 14, 5266-5269 (2012).
42. Dakas, P. Y., Parga, J. A., Hoing, S., Scholer, H. R., Sterneckert, J. & Kumar, K. et al. Discovery of neuritogenic compound classes inspired by natural products. Angew. Chem. Int. Ed. Engl. 52, 9576-9581 (2013).
43. Fan, Y. C. & Kwon, O. Advances in nucleophilic phosphine catalysis of alkenes, allenes, alkynes, and MBHADs. Chem. Commun. 49, 11588-11619 (2013).
44. Lu, Z., Zheng, S. Q., Zhang, X. M. & Lu, X. Y. An unexpected phosphinecatalyzed [3 + 2] annulation. Synthesis of highly functionalized cyclopentenes. Org. Lett. 10, 3267-3270 (2008).
45. Langdon, S. R., Brown, N. & Blagg, J. Scaffold diversity of exemplified medicinal chemistry space. J. Chem. Inf. Model. 51, 2174-2185 (2011).
46. Rogers, D. J. & Tanimoto, T. T. A computer program for classifying plants. Science 132, 1115-1118 (1960).
47. Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742-754 (2010).
48. Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25 (1997).
49. Yan, A. X. & Gasteiger, J. Prediction of aqueous solubility of organic compounds by topological descriptors. Qsar Comb. Sci. 22, 821-829 (2003).
50. Sauer, W. H. B. & Schwarz, M. K. Molecular shape diversity of combinatorial libraries: a prerequisite for broad bioactivity. J. Chem. Inf. Comp. Sci. 43, 987-1003 (2003).
51. Duckert, H. et al. Natural product-inspired cascade synthesis yields modulators of centrosome integrity. Nat. Chem. Biol. 8, 179-184 (2012).
52. Dumontet, C. & Jordan, M. A. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Dis. 9, 790-803 (2010).
53. Atwood, S. X., Chang, A. L. S. & Oro, A. E. Hedgehog pathway inhibition and the race against tumor evolution. J. Cell. Biol. 199, 193-197 (2012).
54. Kawaratani, Y. et al. New microtubule polymerization inhibitors comprising a nitrooxymethylphenyl group. Bioorg. Med. Chem. 19, 3995-4003 (2011).
55. Kavallaris, M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 10, 194-204 (2010).
56. Bhattacharyya, B. & Wolff, J. Promotion of fluorescence upon binding of colchicine to tubulin. Proc. Natl Acad. Sci. USA 71, 2627-2631 (1974).
57. Mullor, J. L., Sanchez, P. & Altaba, A. R. Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 12, 562-569 (2002).
58. McMillan, R. & Matsui, W. Molecular pathways: the hedgehog signaling pathway in cancer. Clin. Cancer Res. 18, 4883-4888 (2012).
59. Nakamura, T. et al. Induction of osteogenic differentiation by hedgehog proteins. Biochem. Bioph. Res. Commun. 237, 465-469 (1997).
60. Wu, X., Walker, J., Zhang, J., Ding, S. & Schultz, P. G. Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem. Biol. 11, 1229-1238 (2004).
61. Sasaki, H., Hui, C. C., Nakafuku, M. & Kondoh, H. A binding site for Gli proteins is essential for HNF-3 beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 124, 1313-1322 (1997).
62. Lipinski, R. J., Gipp, J. J., Zhang, J., Doles, J. D. & Bushman, W. Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. Exp. Cell Res. 312, 1925-1938 (2006).
63. Taipale, J. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005-1009 (2000).
64. Amakye, D., Jagani, Z. & Dorsch, M. Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med. 19, 1410-1422 (2013).
65. Lipkus, A. H. et al. Structural diversity of organic chemistry. A scaffold analysis of the CAS Registry. J. Org. Chem. 73, 4443-4451 (2008).
66. Chen, J. K., Taipale, J., Cooper, M. K. & Beachy, P. A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Gene Dev. 16, 2743-2748 (2002).